BRIM Biotechnology Inc

Activities: Manufacturing Drug Delivery

Trending Articles

  1. Samsung Biologics signs $1.24bn biopharma manufacturing deal with Asian pharmaceutical giant The CDMO will work with the client until the end of 2037, and will use its South Korean biomanufacturing site to serve them
  2. Bespak and H&T Presspart announce availability of GMP pilot line for climate-friendly pMDIs Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze
  3. Astellas' Vyloytm plus chemo gains FDA approval for gastric adenocarcinoma The drug is the first CLDN18.2 targeted therapy to be approved in the US, and can further extend a patient's PFS and OS compared with chemotherapy alone
  4. Axol Bioscience boosts its iPSC bioassay offering with Phenocell acquisition The acquisition will extend Axol's range of iPSC-derived cell lines, including skin and retinal cells — while also expanding its drug discovery services
  5. How AI and GenAI will revolutionise the healthcare industry Artificial intelligence — and particularly its newest iteration, generative artificial intelligence (GenAI) — could bring significant changes to the way we live, work and...

Upcoming event

Lab Innovations

30-31 October 2024 | Exhibition | Birmingham, UK See all

Related Content

Manufacturing

BRIM secures $45.8 million to accelerate regenerative peptides pipeline

BRIM has raised a fund to speed up the development of the company's current clinical trials while enabling it to expand and diversify our pipeline
Subscribe now